StockWatch
·
Specialty Chemicals
Board Meeting24 Oct 2026, 06:20 pm

Chemcon standalone PAT +31% YoY to ₹7.5 Cr on margin gains, eases QoQ off Q1 high

AI Summary

Standalone revenue from operations rose 21.8% YoY to ₹65.45 Cr, with PAT up 30.8% YoY to ₹7.52 Cr (EPS ₹2.05 vs ₹1.57) — the bottom line again outgrew the topline, continuing H1's run of ₹18.48 Cr profit against ₹12.13 Cr a year ago, +52.3%. Margins expanded YoY on both fronts: OPM to 16.87% from 12.76%, NPM to 10.90% from 9.97%, with cost of materials falling to roughly 49% of revenue from ~61% a year earlier — the main driver of the YoY improvement. Sequentially, though, the quarter cooled off an unusually strong Q1: revenue was down 1.6% QoQ, PAT fell 31.4% and OPM retreated from Q1's 23.21% peak — the company's own filing to exchanges frames this plainly as "easing 31% QoQ off strong Q1." The driver sits in the cost lines rather than volumes: Q1 carried a ₹7.61 Cr inventory build that suppressed reported expenses, while Q2 saw a ₹3.64 Cr inventory draw-down that added back to cost, pushing total expenses up to ₹58.88 Cr even as revenue was roughly flat QoQ. There is no analyst consensus or brokerage preview on record for this quarter — Chemcon is a sub-₹1,000 Cr mcap name without regular street coverage, so vsStreet reads unknown rather than a miss. Management has issued no formal numeric guidance either, in our records or around its September 23, 2026 investor meeting, which per its own notice covered "business updates, sector trends and current capacity execution" without quantified targets — so this print is judged purely on its own YoY trend. That capacity-execution backdrop does show up in the P&L: finance costs jumped to ₹0.67 Cr from a near-nil ₹0.09 Cr a year ago, and depreciation rose 37% YoY to ₹3.80 Cr, as current borrowings climbed to ₹27.26 Cr (from effectively nil) and capital work-in-progress held at ₹21.02 Cr — consistent with an expansion still being funded and depreciated ahead of its full volume contribution. Separately, the Board considered declaring a dividend at today's meeting but chose not to, having already paid out ₹23.81 Cr in dividends earlier in H1.

Key Highlights

  • Standalone revenue ₹65.45 Cr (+21.8% YoY, -1.6% QoQ); PAT ₹7.52 Cr (+30.8% YoY, -31.4% QoQ); EPS ₹2.05 vs ₹1.57 a year ago
  • OPM 16.87% vs 12.76% YoY but down from Q1 FY27's 23.21%; NPM 10.90% vs 9.97% YoY but down from Q1's 15.61%
  • QoQ total expenses up ₹3.22 Cr on an inventory swing — Q1's ₹7.61 Cr inventory build vs Q2's ₹3.64 Cr draw-down
  • Finance costs up to ₹0.67 Cr from ₹0.09 Cr YoY; depreciation up 37% YoY to ₹3.80 Cr, with current borrowings at ₹27.26 Cr and CWIP at ₹21.02 Cr funding ongoing capacity expansion
  • H1 FY27 standalone PAT ₹18.48 Cr vs ₹12.13 Cr in H1 FY26, +52.3%
  • Board considered but did not declare a dividend this quarter, after paying ₹23.81 Cr in dividends earlier in H1
  • No management guidance or analyst consensus on record for this quarter